“Game-Changing” New Treatment for Asthma Could Save Millions From Fatal Lung Attacks
A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment failures and improving quality of life. This breakthrough marks a significant advancement after 50 years of stagnant treatment options.
“Game-Changer” Drug Is First New Asthma Attack Treatment In 50 Years
For the first time in half a century, scientists have hit on a new treatment for asthma attacks. Clinical trial results have shown that a drug called benralizumab is effective at treating acute attacks of both asthma and chronic obstructive pulmonary disease (COPD),
Scientists Uncover ‘Game-Changing’ Therapy for Asthma Attacks
The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.
First New Treatment in 50 Years for Asthma Attacks and COPD ‘Could be a Game-Changer’
The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid tablets.
First new asthma attack treatment in 50 years developed
Benralizumab is already used in the most severe cases, but the latest research suggests it could be used routinely for around two million attacks in the UK each year
First new treatment for asthma and COPD in half a century—new study
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged—treatment with steroids,
Revolutionizing Asthma and COPD Treatment: Benralizumab's Promise
A new study reveals benralizumab, an injectable drug, shows promise in reducing asthma and COPD flare-ups, outperforming traditional steroid treatments and minimizing side effects. The drug targets eosinophilic inflammation,
First new asthma treatment in 50 years offers hope for millions
The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.
'Game-Changing' New Treatment for Asthma Is First in 50 Years
Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options in the event of an asthma or COPD attack—a similar event—have been relatively unchanged.
What is benralizumab? Breakthrough asthma drug hailed a 'game-changer'
Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the immune system. The antibody targets a specific group of white blood cells (called eosinophils) to reduce lung inflammation.
First treatment in 50 years for serious asthma attacks is ‘game-changer’
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.
emjreviews.com21h
Eosinophilic Inflammation in Focus: New Trial Data
Discover how benralizumab offers superior outcomes for eosinophilic asthma and COPD exacerbations, outperforming steroids in ...
Health and Me on MSN5d
No Steroids Needed: An Existing Drug Can Help Asthma And COPD Patients, Reveals Lancet Study
A clinical trial reveals that benralizumab, an injectable drug for severe asthma, outperforms steroids in reducing asthma and ...
Hoodline4d
Revolutionary 'Game-Changer' Drug Takes the Fight to Asthma and COPD, Boasts 45% Treatment Success Leap at King's College London
A study reveals Benralizumab as a new treatment for asthma and COPD, reducing treatment failure rates significantly.
India Today on MSN4d
First Asthma treatment in 50 years: Scientists make big medical breakthrough
Scientists have discovered that benralizumab, a drug currently used for severe asthma, can be repurposed in emergency ...
Asthma attack breakthrough as experts edge closer to first leap in treatment in 50 years
A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and ...